Regulation of PINK1 by NR2B-containing NMDA receptors in ischemic neuronal injury

Journal of Neurochemistry

Volumn 111, Issue 5, 2009, Pages 1149-1160

  Shan, Yuexin ^a   Liu, Baosong ^a   Li, Lijun ^a   Chang, Ning ^a   Li, Lei ^b   Wang, Hanbin ^c   Wang, Dianshi ^a   Feng, Hua ^d   Cheung, Carol ^e   Liao, Mingxia ^f   Cui, Tianyuan ^f   Sugita, Shuzo ^a   Wan, Qi ^a,f  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

^d Beijing 307 Hospital   (China)

^e SOUTHWEST HOSPITAL   (China)

^f UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Akt; Ischemia; NMDA receptor; Oxygen glucose deprivation; PTEN induced kinase 1; Signal transduction

Indexed keywords

GLUCOSE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; OXYGEN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CELL CULTURE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EXPERIMENTAL TEST; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; ISCHEMIC NEURON INJURY; NERVE DEGENERATION; NERVE INJURY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXYGEN GLUCOSE DEPRIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANOXIA; CELLS, CULTURED; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE; GREEN FLUORESCENT PROTEINS; L-LACTATE DEHYDROGENASE; MEMBRANE POTENTIALS; NEURONS; PATCH-CLAMP TECHNIQUES; PREGNANCY; PROTEIN KINASES; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, SMALL INTERFERING; TIME FACTORS; TRANSFECTION;

EID: 70350755626     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06398.x     Document Type: Article

References (51)

1. Aarts M. M., Arundine M. Tymianski M. (2003) Novel concepts in excitotoxic neurodegeneration after stroke. Expert Rev. Mol. Med. 5, 1 22.
2. Arundine M. Tymianski M. (2004) Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell. Mol. Life Sci. 61, 657 668.
3. Auberson Y. P., Allgeier H., Bischoff S., Lingenhoehl K., Moretti R. Schmutz M. (2002) 5- Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition. Bioorg. Med. Chem. Lett. 12, 1099 1102.
4. Beilina A., Van Der Brug M., Ahmad R., Kesavapany S., Miller D. W., Petsko G. A. Cookson M. R. (2005) Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc. Natl Acad. Sci. USA 102, 5703 5708. Epub 2005 Apr 5711.
5. Brewer G. J. (1995) Serum-free B27/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrus. J. Neurosci. Res. 42, 674 683.
6. Chang N., El-Hayek Y. H., Gomez E. Wan Q. (2007) Phosphatase PTEN in neuronal injury and brain disorders. Trends Neurosci. 30, 581 586.
7. Chen M., Lu T. J., Chen X. J., Zhou Y., Chen Q., Feng X. Y., Xu L., Duan W. H. Xiong Z. Q. (2008) Differential roles of NMDA receptor subtypes in ischemic neuronal cell death and ischemic tolerance. Stroke 39, 3042 3048.
8. Clark I. E., Dodson M. W., Jiang C., Cao J. H., Huh J. R., Seol J. H., Yoo S. J., Hay B. A. Guo M. (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441, 1162 1166. Epub 2006 May 1163.
9. Cull-Candy S., Brickley S. Farrant M. (2001) NMDA receptor subunits: diversity, development and disease. Curr. Opin. Neurobiol. 11, 327 335.
10. Deng H., Jankovic J., Guo Y., Xie W. Le W. (2005) Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SH-SY5Y. Biochem. Biophys. Res. Commun. 337, 1133 1138. Epub 2005 Oct 1136.
11. DeRidder M. N., Simon M. J., Siman R., Auberson Y. P., Raghupathi R. Meaney D. F. (2006) Traumatic mechanical injury to the hippocampus in vitro causes regional caspase-3 and calpain activation that is influenced by NMDA receptor subunit composition. Neurobiol. Dis. 22, 165 176.
12. Dingledine R., Borges K., Bowie D. Traynelis S. F. (1999) The glutamate receptor ion channels. Pharmacol. Rev. 51, 7 61.
13. Dirnagl U., Iadecola C. Moskowitz M. A. (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391 397.
14. von Engelhardt J., Coserea I., Pawlak V., Fuchs E. C., Kohr G., Seeburg P. H. Monyer H. (2007) Excitotoxicity in vitro by NR2A- and NR2B-containing NMDA receptors. Neuropharmacology 53, 10 17.
15. Fischer G., Mutel V., Trube G., Malherbe P., Kew J. N., Mohacsi E., Heitz M. P. Kemp J. A. (1997) Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro. J. Pharmacol. Exp. Ther. 283, 1285 1292.
16. Gandhi S., Muqit M. M., Stanyer L. et al. (2006) PINK1 protein in normal human brain and Parkinson's disease. Brain 129, 1720 1731. Epub 2006 May 1715.
17. Gascon S., Deogracias R., Sobrado M., Roda J. M., Renart J., Rodriguez-Pena A. Diaz-Guerra M. (2005) Transcription of the NR1 subunit of the N-methyl-D-aspartate receptor is down-regulated by excitotoxic stimulation and cerebral ischemia. J. Biol. Chem. 280, 35018 35027.
18. Green D. R. Kroemer G. (2004) The pathophysiology of mitochondrial cell death. Science 305, 626 629.
19. Hansson O., Petersen A., Leist M., Nicotera P., Castilho R. F. Brundin P. (1999) Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. Proc. Natl Acad. Sci. USA 96, 8727 8732.
20. Hardingham G. E., Fukunaga Y. Bading H. (2002) Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat. Neurosci. 5, 405 414.
21. Ikonomidou C. Turski L. (2002) Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol. 1, 383 386.
22. Kemp J. A. McKernan R. M. (2002) NMDA receptor pathways as drug targets. Nat. Neurosci. 5, 1039 1042.
23. Kew J. N. Kemp J. A. (1998) An allosteric interaction between the NMDA receptor polyamine and ifenprodil sites in rat cultured cortical neurones. J. Physiol. 512 (Pt 1) 17 28.
24. Kitada T., Pisani A., Porter D. R., Yamaguchi H., Tscherter A., Martella G., Bonsi P., Zhang C., Pothos E. N. Shen J. (2007) Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice. Proc. Natl Acad. Sci. USA 104, 11441 11446.
25. Lee J. M., Zipfel G. J. Choi D. W. (1999) The changing landscape of ischaemic brain injury mechanisms. Nature 399, 7 14.
26. Lipton P. (1999) Ischemic cell death in brain neurons. Physiol. Rev. 79, 1431 1568.
27. Liu B., Liao M., Mielke J. G. et al. (2006) Ischemic insults direct glutamate receptor subunit 2-lacking AMPA receptors to synaptic sites. J. Neurosci. 26, 5309 5319.
28. Liu Y., Wong T. P., Aarts M. et al. (2007) NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J. Neurosci. 27, 2846 2857.
29. Luo H. R., Hattori H., Hossain M. A., Hester L., Huang Y., Lee-Kwon W., Donowitz M., Nagata E. Snyder S. H. (2003) Akt as a mediator of cell death. Proc. Natl Acad. Sci. USA 100, 11712 11717. Epub 12003 Sep 11722.
30. Martel M. A., Wyllie D. J. Hardingham G. E. (2009) In developing hippocampal neurons, NR2B- containing N-methyl-d-aspartate receptors (NMDARs) can mediate signaling to neuronal survival and synaptic potentiation, as well as neuronal death. Neuroscience 158, 334 343.
31. Mielke J. G. Wang Y. T. (2005) Insulin exerts neuroprotection by counteracting the decrease in cell- surface GABA receptors following oxygen-glucose deprivation in cultured cortical neurons. J. Neurochem. 92, 103 113.
32. Ning K., Pei L., Liao M. et al. (2004) Dual neuroprotective signaling mediated by downregulating two distinct phosphatase activities of PTEN. J. Neurosci. 24, 4052 4060.
33. Noshita N., Sugawara T., Lewen A., Hayashi T. Chan P. H. (2003) Copper-zinc superoxide dismutase affects Akt activation after transient focal cerebral ischemia in mice. Stroke 34, 1513 1518.
34. Park J., Lee S. B., Lee S. et al. (2006) Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441, 1157 1161. Epub 2006 May 1153.
35. Passafaro M., Piech V. Sheng M. (2001) Subunit-specific temporal and spatial patterns of AMPA receptor exocytosis in hippocampal neurons. Nat. Neurosci. 4, 917 926.
36. Petit A., Kawarai T., Paitel E. et al. (2005) Wild- type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J. Biol. Chem. 280, 34025 34032.
37. Plun-Favreau H., Klupsch K., Moisoi N. et al. (2007) The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat. Cell Biol. 9, 1243 1252. Epub 2007 Sep 1230.
38. Pridgeon J. W., Olzmann J. A., Chin L. S. Li L. (2007) PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1. PLoS Biol. 5, e172.
39. Rao V. R. Finkbeiner S. (2007) NMDA and AMPA receptors: old channels, new tricks. Trends Neurosci. 30, 284 291.
40. Rumbaugh G. Vicini S. (1999) Distinct synaptic and extrasynaptic NMDA receptors in developing cerebellar granule neurons. J. Neurosci. 19, 10603 10610.
41. Sarraf-Yazdi S., Sheng H., Miura Y., McFarlane C., Dexter F., Pearlstein R. Warner D. S. (1998) Relative neuroprotective effects of dizocilpine and isoflurane during focal cerebral ischemia in the rat. Anesth. Analg. 87, 72 78.
42. Silvestri L., Caputo V., Bellacchio E., Atorino L., Dallapiccola B., Valente E. M. Casari G. (2005) Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum. Mol. Genet. 14, 3477 3492. Epub 2005 Oct 3475.
43. Steinberg G. K., Panahian N., Perez-Pinzon M. A., Sun G. H., Modi M. W. Sepinwall J. (1995) Narrow temporal therapeutic window for NMDA antagonist protection against focal cerebral ischaemia. Neurobiol. Dis. 2, 109 118.
44. Tovar K. R. Westbrook G. L. (1999) The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J. Neurosci. 19, 4180 4188.
45. Unoki M. Nakamura Y. (2001) Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway. Oncogene 20, 4457 4465.
46. Valente E. M., Abou-Sleiman P. M., Caputo V. et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158 1160. Epub 2004 Apr 1115.
47. Vanhoutte P. Bading H. (2003) Opposing roles of synaptic and extrasynaptic NMDA receptors in neuronal calcium signalling and BDNF gene regulation. Curr. Opin. Neurobiol. 13, 366 371.
48. Wan Q., Xiong Z. G., Man H. Y., Ackerley C. A., Braunton J., Lu W. Y., Becker L. E., MacDonald J. F. Wang Y. T. (1997) Recruitment of functional GABA(A) receptors to postsynaptic domains by insulin. Nature 388, 686 690.
49. Wang D., Qian L., Xiong H., Liu J., Neckameyer W. S., Oldham S., Xia K., Wang J., Bodmer R. Zhang Z. (2006) Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila. Proc. Natl Acad. Sci. USA 103, 13520 13525. Epub 12006 Aug 13524.
50. Wang H. L., Chou A. H., Yeh T. H., Li A. H., Chen Y. L., Kuo Y. L., Tsai S. R. Yu S. T. (2007) PINK1 mutants associated with recessive Parkinson's disease are defective in inhibiting mitochondrial release of cytochrome c. Neurobiol. Dis. 28, 216 226. Epub 2007 Jul 2017.
51. Yang Y., Gehrke S., Imai Y., Huang Z., Ouyang Y., Wang J. W., Yang L., Beal M. F., Vogel H. Lu B. (2006) Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc. Natl Acad. Sci. USA 103, 10793 10798.